These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16054717)

  • 1. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial).
    Jørgensen E; Ripa RS; Helqvist S; Wang Y; Johnsen HE; Grande P; Kastrup J
    Int J Cardiol; 2006 Jul; 111(1):174-7. PubMed ID: 16054717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instent neointimal hyperplasia after percutaneous intervention for ST-elevation myocardial infarction and treatment with granulocyte-colony stimulating factor. Results from the stem cells in myocardial infarction (STEMMI) trial.
    Jørgensen E; Baldazzi F; Ripa RS; Friis T; Wang Y; Helqvist S; Kastrup J
    Int J Cardiol; 2010 Mar; 139(3):269-75. PubMed ID: 19056135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
    Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
    JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
    Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
    Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
    Kang HJ; Kim HS; Zhang SY; Park KW; Cho HJ; Koo BK; Kim YJ; Soo Lee D; Sohn DW; Han KS; Oh BH; Lee MM; Park YB
    Lancet; 2004 Mar; 363(9411):751-6. PubMed ID: 15016484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells mobilization in acute myocardial infarction (stem-AMI trial): preliminary data of a perspective, randomized, single blind trial.
    Malafronte C; Achilli F
    Minerva Cardioangiol; 2007 Dec; 55(6):721-31. PubMed ID: 18091641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of granulocyte-colony stimulating factor in bare stent and sirolimus-eluting stent in pigs following myocardial infarction.
    Lim SY; Kim YS; Ahn Y; Jeong MH; Rok LS; Kim JH; Kim KH; Park HW; Kim W; Cho JG; Park JC; Kang PM; Schwartz RS; Kang JC
    Int J Cardiol; 2007 Jun; 118(3):304-11. PubMed ID: 17052793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.
    Steinwender C; Hofmann R; Kammler J; Kypta A; Pichler R; Maschek W; Schuster G; Gabriel C; Leisch F
    Am Heart J; 2006 Jun; 151(6):1296.e7-13. PubMed ID: 16781240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial.
    Steppich B; Hadamitzky M; Ibrahim T; Groha P; Schunkert H; Laugwitz KL; Kastrati A; Ott I;
    Thromb Haemost; 2016 Apr; 115(4):864-8. PubMed ID: 26790705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial.
    Iwata Y; Fujimoto Y; Morino T; Sugimoto K; Ohkubo K; Kadohira T; Fukushima K; Kitahara H; Komuro I; Kobayashi Y
    Am Heart J; 2013 Mar; 165(3):408-14. PubMed ID: 23453111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.
    Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G;
    Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
    Kang HJ; Kim YS; Koo BK; Park KW; Lee HY; Sohn DW; Oh BH; Park YB; Kim HS
    Heart; 2008 May; 94(5):604-9. PubMed ID: 18070947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of stem cell mobilization by granulocyte colony-stimulating factor in the treatment of acute myocardial infarction.
    Fan L; Chen L; Chen X; Fu F
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):45-54. PubMed ID: 18000749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
    Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
    Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial.
    Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Staico R; Feres F; Centemero M; Tanajura LF; Abizaid A; Pinto I; Maldonado G; Seixas A; Costa MA; Paes A; Mintz GS; Sousa JE
    Circulation; 2004 Feb; 109(7):861-6. PubMed ID: 14757690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.